Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-002126-90Phase 3Completed
Phase 3 trial of lidocaine, dexmedetomidine, remifentanil and morphine in cardiac morbidity (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Primary composite endpoint. Started Dec 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-002126-90.